First Trust Direct Indexing’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,641
Closed -$451K 822
2024
Q3
$451K Sell
5,641
-13
-0.2% -$977 0.02% 577
2024
Q2
$405K Buy
5,654
+793
+16% +$58.4K 0.03% 561
2024
Q1
$342K Buy
4,861
+93
+2% +$6.66K 0.03% 579
2023
Q4
$368K Buy
4,768
+388
+9% +$25.6K 0.03% 523
2023
Q3
$298K Sell
4,380
-711
-14% -$56.2K 0.03% 521
2023
Q2
$416K Buy
5,091
+431
+9% +$34.6K 0.05% 461
2023
Q1
$346K Buy
4,660
+636
+16% +$49K 0.04% 500
2022
Q4
$334K Sell
4,024
-176
-4% -$14K 0.04% 479
2022
Q3
$298K Buy
4,200
+388
+10% +$33.5K 0.04% 469
2022
Q2
$330K Buy
3,812
+180
+5% +$16.9K 0.05% 444
2022
Q1
$393K Sell
3,632
-4
-0.1% -$413 0.05% 426
2021
Q4
$470K Sell
3,636
-132
-4% -$16.2K 0.06% 369
2021
Q3
$456K Buy
3,768
+212
+6% +$25.8K 0.06% 373
2021
Q2
$400K Buy
+3,556
New +$374K 0.06% 383

Other funds holding TECH

First Trust Direct Indexing's TECH Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Bio-Techne (TECH) in Q4 2024, closing a stake of 5,641 shares — an estimated $451K sold.

First Trust Direct Indexing first reported a position in TECH in Q2 2021 and held it in 14 quarters. The position peaked at $470K in Q4 2021. 577 funds tracked by Wall St. Rank hold TECH as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Bio-Techne position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 5,641 Bio-Techne shares in Q4 2024, an estimated $451K.
  • First Trust Direct Indexing first reported a position in Bio-Techne in Q2 2021 and held it in 14 quarters.
  • First Trust Direct Indexing's Bio-Techne position peaked at $470K in Q4 2021.
  • 577 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.